| 摘要 |
<p>A formulation for use in an inhaler device comprises carrier particles having a diameter of at least 50νm and a mass median diameter of at least 175νm; fine particles of an excipient material having a mass median aerodynamic diameter of not more than 20νm; and active particles. The formulation has excellent flowability even at relatively high contents of fine particles.</p> |
